Shengxiang H. Ren
No. 507, Zheng Min Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 233 publications
International Consensus on Severe Lung Cancer-The Second Edition.
Journal: Translational lung cancer research
Published: March 21, 2026
Expert consensus on the detection and clinical application of tumor mutational burden.
Journal: Cancer biology & medicine
Published: February 18, 2026
SHR-A2102, a nectin-4 directed antibody-drug conjugate, in patients with pretreated advanced solid tumours: a multicentre, single-arm, phase 1 trial.
Journal: The Lancet. Oncology
Published: January 13, 2026
Cryoablation Activates the cGAS-STING-CXCL10 Axis in Macrophages to Enhance Anti-Tumor Immunity in NSCLC.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 31, 2025
Case Report: Complete pathologic response to neoadjuvant immunotherapy-chemotherapy in a patient with RET fusion-positive non-small cell lung cancer.
Journal: Frontiers in oncology
Published: October 23, 2025
Recent Advances in the Treatment of Non-small Cell Lung Cancer with Brigatinib
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: July 10, 2025
Ensemble learning on serum metabolic fingerprints for early detection of lung adenocarcinoma.
Journal: NPJ precision oncology
Published: June 26, 2025
Development of a bispecific antibody that inhibits EGFR and B7H3 in NSCLC.
Journal: Biomarker research
Published: June 23, 2025
Biomarkers and ImmuneScores in lung cancer: predictive insights for immunotherapy and combination treatment strategies.
Journal: Biological procedures online
Published: May 05, 2025
International guidelines on the diagnosis and treatment of NUT carcinoma.
Journal: Innovation (Cambridge (Mass.))
Published: April 11, 2025
Ablation plus immunotherapy versus immunotherapy alone in patients of advanced NSCLC who develop oligo-residual disease after anti-PD-1/L1 therapy (BOOSTER): a randomized phase 2 trial.
Journal: Signal transduction and targeted therapy
Published: April 03, 2025
Last Updated: 09/26/2026